Mitsubishi Tanabe Pharma Europe acts as the European Headquarters of one of Japan's leading pharmaceutical companies, Mitsubishi Tanabe Pharma Corporation. Based in London, we are dedicated to the clinical development of new medicines for the European markets. We are marketing authorisations holder and also support commercial operations for other in-house products.
Making new medicines available for patients is a complex process taking many years, in which our company investigates thousands of potential new medicines for every one that proves to be safe, effective, and can be prescribed by doctors. Our headquarters, Mitsubishi Tanabe Pharma Corporation, based in Japan, is involved in many research projects into many different diseases, some of which involve Mitsubishi Tanabe Pharma Europe.
Making new medicines available for patients is a complex process taking many years, in which our company investigates thousands of potential new medicines for every one that proves to be safe, effective, and can be prescribed by doctors. Our headquarters, Mitsubishi Tanabe Pharma Corporation, based in Japan, is involved in many research projects into many different diseases, some of which involve Mitsubishi Tanabe Pharma Europe.
Services
Mitsubishi Pharma Europe Ltd was established in 2001 with headquarters based in London. We also have business operations in Germany, Austria and Switzerland, our subsidiary company, Mitsubishi Tanabe Pharma GmbH, is responsible for the distribution, sales and marketing activities in the German, Austrian and Swiss territories.
Mitsubishi Tanabe Pharma Europe Ltd is the European Headquarters of one of Japan's largest pharmaceutical companies, Mitsubishi Tanabe Pharma Corporation. Mitsubishi Tanabe Pharma Corporation is committed to becoming a global research-driven pharmaceutical company, which continuously brings new medicines to market that meet global needs.
We are committed to meet the highest standards of ethics and corporate compliance as specified in the Mitsubishi Tanabe Pharma Group Philosophy, Vision and Corporate Behaviour Charter. We contribute to the healthier lives of people around the world through the creation of pharmaceuticals. We strive to be a global research-driven pharmaceutical company that is trusted by society.
The Mitsubishi Tanabe Pharma Group engages Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs) across Europe. We are committed to ensuring transparency in our interaction with HCPs and HCOs. In accordance with the EFPIA Code of Transfers of Value from Pharmaceutical Companies 2014, details of Transfers of Value made to HCPs and HCOs in Europe by the Mitsubishi Tanabe Pharma Group can be found below.
Making new medicines available for patients is a complex process taking many years, in which our company investigates thousands of potential new medicines for every one that proves to be safe, effective, and can be prescribed by doctors. Target discovery: Detailed knowledge of disease processes at the molecular level allows us to determine how and where a candidate medicine may act.
Reviews
Be the first to review Mitsubishi Tanabe Pharma Europe.
Write a Review
